- ASSISTANT CLINICAL PROFESSOR Dentistry
American Board of Oral/Maxillofacial Surgery
MD, Higher Medical Institute Sofia
B.A., Fine Arts School
D.D.S., New York University, College of Dentistry
Bellevue Hopsital Center, Department of Oral and Maxillofacial Surgery
The Catholoic University, St. Radboud Hospital
Residency, Oral & Maxillofacial
Montefiore Medical Center
University of Munster
- Dr. Anastassov has extensive training and expertise in treatment of congenital and acquired craniofacial malformations, such as cleft lip and/ or palate, syndromes affecting craniofacial growth and development as well as craniofacial trauma, reconstructive surgery and aesthetic surgery. Dr. Anastassov was privileged to train in some of the most respected educational programs in United States and Europe. He is trained in oral/maxillofacial surgery, plastic surgery and craniofacial and base of the skull surgery.
Dr. Anastassov has lectured extensively on topics ranging from oral implantology to aesthetic, reconstructive and trauma surgery in the United States, Colombia, Mexico, Germany, France, Switzerland, Scotland, Italy, The Netherlands, Romania, Bulgaria, Ukraine, Russia, and so on. Dr. Anastassov has also operated pro bono in most of these countries on children and young adults with craniofacial malformations.
Dr. Anastassov has published extensively in the fields of craniofacial surgery, aesthetic surgery, reconstructive surgery, and dental implantology. Dr. Anastassov's scientific interests are related to the influence of early vs. delayed surgical treatment of cleft lip and/ or palate deformity. The International Cleft Lip and Palate Foundation rate the cleft lip and palate center organized by Dr. Anastassov at the Elmhurst Hospital Center as an Center of Excellence.
Dr. Anastassov is an active member of the American Association of Oral and Maxillofacial Surgeons, European Association for Craniomaxillofacial Surgery, American College of Oral and Maxillofacial Surgeons, The International Cleft Lip and Palate Foundation, and the Hellenic Medical Society of New York. Dr. Anastassov serves on the editorial board or is a reviewer for the following peer reviewed professional journals: The Journal of Oral Surgery, Oral Medicine, Oral Pathology and Radiology (Triple O); The International Journal of Oral and Maxillofacial Surgery; and Folia Medica.
Anastassov GE, Lee H. Respiratory mucocele formation after augmentation genioplasty with nasal osteocartilaginous graft. J Oral Maxillofac Surg 1999 Oct; 57(10): 1263-5.
Anastassov GE, Asher ES. Peri-implant skin graft for a craniofacial prosthesis. J Prosthet Dent. 2000 Aug; 84(2): 215-6.
Anastassov GE, Haiavy J, Solodnik P, Lee H, Lumerman H. Submandibular gland mucocele: diagnosis and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000 Feb; 89(2): 159-63.
Anastassov GE, Lee H, Schneider R. Arthroscopic reduction of a high condylar process fracture: a case report. J Oral Maxillofac Surg 2000 Sep; 58(9): 1048-51.
Anastassov GE, Lee H, Haiavy J. Discoplasty with autogenous superficial musculoaponeurotic system (SMAS) flap in reconstruction of the temporomandibular joint combined with cervicofacial rhytidectomy. Br J Oral Maxillofac Surg 2000 Aug; 38(4): 346-9.
Anastassov GE. In reply. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000 Oct; 90(4): 405.
Anastassov GE, Joos U. Comprehensive management of cleft lip and palate deformities. J Oral Maxillofac Surg 2001 Sep; 59(9): 1062-75.
Anastassov GE, Schwartz S, Rodriguez E. Buccinator myomucosal island flap for postablative maxillofacial reconstructions: a report of 4 cases. J Oral Maxillofac Surg 2002 Jul; 60(7): 816-21.
Rodriguez A, Anastassov GE, Lee H, Buchbinder D, Wettan H. Maxillary sinus augmentation with deproteinated bovine bone and platelet rich plasma with simultaneous insertion of endosseous implants. J Oral Maxillofac Surg 2003 Feb; 61(2): 157-63.
Anastassov GE, Anastassov YC, Lumerman HS, Simov R, Shipkov CD, Mihailov TA, Traikova N. Craniofacial fibrous dysplasia. conservative surgical management. Review of literature and report of a case [review]. Folia Med (Plovdiv) 2004; 46(2): 56-61.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Anastassov during 2014 and/or 2015. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- CanChew Biotechnologies
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Health System (MSHS) physicians - including those employed by MSHS - do not always participate in the same health plans in which MSHS hospitals or facilities participate.
Information regarding insurance participation and billing by this physician may be found on this page or obtained by contacting this provider directly.
Insurance plans that the Mount Sinai Health System hospitals or facilities participate in can be found on the Mount Sinai Health System website.
18 East 50 Street
New York, NY 10022